Publications

6434 items matching your search terms.

Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation

Musgrove, E. A.;Sarcevic, B.;Sutherland, R. L. :

JOURNAL OF CELLULAR BIOCHEMISTRY 60 (3) :363-78, 1996

Treatment options in acromegaly. Benefits and costs

Weekes, L. M.;Ho, K. K.;Seale, J. P. :

PHARMACOECONOMICS 10 (5) :453-9, 1996

Metabolic actions of growth hormone in man

Ho, K. K.;O'Sullivan, A. J.;Hoffman, D. M. :

ENDOCRINE JOURNAL 43 Suppl :S57-63, 1996

Exercise and insulin-dependent diabetes mellitus (IDDM): benefits and pitfalls

Choi, K. L.;Chisholm, D. J. :

Aust N Z J Med 26 (6) :827-33, 1996

Glycine: the other inhibitory neurotransmitter

Schofield, P. :

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 20 (8 Suppl) :219A-223A, 1996

A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors

Mascia, M. P.;Mihic, S. J.;Valenzuela, C. F.;Schofield, P. R.;Harris, R. A. :

MOLECULAR PHARMACOLOGY 50 (2) :402-6, 1996

Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester

Lee, C. S.;deFazio, A.;Ormandy, C. J.;Sutherland, R. L. :

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 58 (3) :267-75, 1996

Conservative management of fibroadenoma of the breast

Alle, K. M. :

BRITISH JOURNAL OF SURGERY 83 :1298-1799, 1996

Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells

Wilcken, N. R.;Sarcevic, B.;Musgrove, E. A.;Sutherland, R. L. :

Cell Growth Differ 7 (1) :65-74, 1996

Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor

Sautel, M.;Rudolf, K.;Wittneben, H.;Herzog, H.;Martinez, R.;Munoz, M.;Eberlein, W.;Engel, W.;Walker, P.;Beck-Sickinger, A. G. :

MOLECULAR PHARMACOLOGY 50 (2) :285-92, 1996

Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence

Tseng, A.;Inglis, A. S.;Scott, K. F. :

JOURNAL OF BIOLOGICAL CHEMISTRY 271 (39) :23992-8, 1996

Glycemic responses to exercise in IDDM after simple and complex carbohydrate supplementation

Soo, K.;Furler, S. M.;Samaras, K.;Jenkins, A. B.;Campbell, L. V.;Chisholm, D. J. :

DIABETES CARE 19 (6) :575-9, 1996

Structural and biochemical studies of human galanin: NMR evidence for nascent helical structures in aqueous solution

Morris, M. B.;Ralston, G. B.;Biden, T. J.;Browne, C. L.;King, G. F.;Iismaa, T. P. :

Biochemistry 34 (14) :4538-45, 1995

Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells

Fiddes, R. J.;Janes, P. W.;Sanderson, G. M.;Sivertsen, S. P.;Sutherland, R. L.;Daly, R. J. :

Cell Growth Differ 6 (12) :1567-77, 1995

Defining growth hormone deficiency in adults

Ho, K. K.;Hoffman, D. M. :

METABOLISM-CLINICAL AND EXPERIMENTAL 44 (10 Suppl 4) :91-6, 1995

Genetic regulation of peak bone mass

Kelly, P. J.;Harris, M. :

Acta Paediatr Suppl 411 :24-9; discussion 30, 1995